Extended-release Sodium Oxybate in Children
A legfontosabb adatok
- Hol
- Redwood City (Egyesült Államok)A helyszín megnézése
- Fázis
- 2. fázis
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 7 és 17 év között vagy?
Forrás: NCT06809803: ki vehet részt
Helyszínek itt: Egyesült Államok
- Stanford UniversityRedwood City, Egyesült ÁllamokContact: Miran ChoRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Stanford University
- Azonosító
- NCT06809803
- A regiszteradat frissítve
- 2025. november 6.
- Eredeti leírás
The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sodium oxybates). The study will also assess the safety, convenience, and tolerability of Extended-release sodium oxybate. Additionally, the researchers aim to assess how well Extended-release sodium oxybate works in treating narcolepsy type 1.A teljes eredeti leírásKevesebb
Safety, Convenience, and Tolerability of a Nightly Single Oral Dose of Extended-release Sodium Oxybate in Children
The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sodium oxybates). The study will also assess the safety, convenience, and tolerability of Extended-release sodium oxybate. Additionally, the researchers aim to assess how well Extended-release sodium oxybate works in treating narcolepsy type 1.
Bevonási feltételek: Participants must be under the care of a doctor at the Stanford Sleep Clinic; Participants must have a documented diagnosis of narcolepsy type 1 shown by sleepiness and either: a spinal fluid marker for narcolepsy (hypocretin-1) at a specific level, or a history of sudden loss of muscle control (cataplexy), or a particular genetic marker for narcolepsy, or a sleep study showing a specific sleep pattern for narcolepsy; Parent(s), or guardian(s) have signed a consent form and the child must agree to participate; Participants are on a stable dose of medications.
Kizáró feltételek: Currently having a problem with illegal drug use; Participants who have any of the following conditions will not be included in the study; Uncontrolled mental health problems; Uncontrolled sleep problems that lead to sleepiness; Currently having thought about ending one's life or sadness or loss of interest; Currently pregnant.